Stethoscope

Publix opens fourth telehealth site with Beaufort Memorial Hospital

Retrieved on: 
Tuesday, January 17, 2023
Men, Retail, Health, Family, Consumer, Pharmaceutical, Telemedicine, Virtual Medicine, General Health, Hospitals, Supermarket, Health Technology, Health Insurance, Women, Seniors, Rash, Publix, Pharmacy, Fever, Patient, Diagnosis, Influenza, Prescription, Stethoscope, Hospital

Publix Pharmacy is opening its fourth telehealth site with Beaufort Memorial Hospital in Beaufort, South Carolina.

Key Points: 
  • Publix Pharmacy is opening its fourth telehealth site with Beaufort Memorial Hospital in Beaufort, South Carolina.
  • The telehealth site will be located inside store #1716, located at 33 Robert Smalls Parkway, Beaufort, South Carolina.
  • “Publix Pharmacy looks forward to extending new, convenient services to even more communities with the help of Beaufort Memorial Hospital,” said Vice President of Publix Pharmacy Dain Rusk.
  • Publix Pharmacy associates sanitize the room and equipment after each use and are available to assist patients, if needed.

Thinklabs Teams Up with eMurmur® to Provide Remote Auscultation Capabilities

Retrieved on: 
Thursday, December 8, 2022
Auscultation, School, Heart, Nursing, Health, Telehealth, Patient, Lung, Stethoscope, Hospital, Medical imaging

CENTENNIAL, Colo., Dec. 8, 2022 /PRNewswire/ -- Thinklabs Medical and eMurmur® today announced a new remote auscultation system that provides advanced auscultation capability. The system is based on the best-in-class Thinklabs One Digital Stethoscope and eMurmur's cloud-based auscultation platform.

Key Points: 
  • CENTENNIAL, Colo., Dec. 8, 2022 /PRNewswire/ --Thinklabs Medical and eMurmur today announced a new remote auscultation system that provides advanced auscultation capability.
  • The Thinklabs One stethoscope, paired with eMurmur's powerful digital auscultation platform, opens up exciting new possibilities in remote patient monitoring.
  • Examples include remote virtual auscultation for telemedicine, home-based heart and lung health screening, asynchronous specialist consultations, or bedside auscultation teaching.
  • Andreas Schriefl, eMurmur CEO: "The unique design of the Thinklabs One digital stethoscope, paired with our eMurmur software, makes it a great system for tele- auscultation.

Eko Named to 2022 CB Insights Digital Health 150

Retrieved on: 
Thursday, December 8, 2022
CB Insights, Heart, Digital technology, R, AR, Economist Intelligence Unit, Health, Patient, Heart sounds, Research, Digital, Rest, FDA, SVP, Artificial intelligence, Stethoscope, Digital health, Degenerative disease, Machine learning, Medical device, Diagnosis, Mosaic

OAKLAND, Calif., Dec. 8, 2022 /PRNewswire/ -- Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was named to the 2022 CB Insights Digital Health 150 list. This is the third consecutive year that Eko has been included in the list of 150 of the most promising, private digital healthcare companies in the world.

Key Points: 
  • OAKLAND, Calif., Dec. 8, 2022 /PRNewswire/ -- Eko , a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was named to the 2022 CB Insights Digital Health 150 list .
  • This is the third consecutive year that Eko has been included in the list of 150 of the most promising, private digital healthcare companies in the world.
  • "From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year's Digital Health 150 winners are transforming the future of healthcare with digital technology," said Brian Lee, SVP of CB Insights' Intelligence Unit.
  • Eko is committed to impacting patient care in a meaningful way by providing digital tools that solve important clinical problems."

Patients are at Continuous Risk of Exposure to Pathogens, Warn Experts, Unless Effective Solutions for Stethoscope Hygiene are Integrated

Retrieved on: 
Friday, November 11, 2022
Infection, Acoustics, UC, Patient safety, Cancer, CDC, UC San Diego Health, Approximation error, Compliance, Technology, Solution, Risk, SAN, Hand, Patient, Stethoscope, American Journal of Infection Control, UC Berkeley – UCSF Joint Medical Program, American Journal, Gaps, Time, Physician, Pharmaceutical industry, Vaccine, Medical device, Tissue paper

The article also explores the challenges and pitfalls that are characteristic of the current standards of stethoscope hygiene.

Key Points: 
  • The article also explores the challenges and pitfalls that are characteristic of the current standards of stethoscope hygiene.
  • Additionally, the authors suggest that stethoscope hygiene innovation, in the form of touch free aseptic barriers, provide an opportunity to address the threat of healthcare associated infection transmission by the stethoscope.
  • It is a ubiquitous, valuable clinical tool and an enduring symbol of the trust between healthcare providers and patients.
  • The stethoscope is also a proven vector of pathogen transmission, with CDC cleaning guidelines that are incompatible with the intensity of stethoscope use and the high-paced workflow in clinical settings.

Stethoscope Sales Set to Total US$ 504 Million by 2026 as Advancement in Stethoscope Technology Surges

Retrieved on: 
Wednesday, September 14, 2022
Incidence, Electrification, Prevalence, Eko, Digitalization, NEW, Stethoscope, Growth, 3M, Patient, Johns Hopkins University, Physician, Diagnosis, Artificial intelligence, Lists of countries and territories, AI, Conditional sentence, CAGR, Medical device, Pharmaceutical industry

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- The global stethoscopes market is likely to grow from US$ 431 million in 2022 to US$ 504 million by 2026, with sales accelerating at a CAGR of 4% between 2022 and 2026. Rising prevalence of chronic diseases and growing need for better diagnosis and treatment of patients are some of the key factors driving growth in the global stethoscopes market.

Key Points: 
  • Massive Electrification and Digitalization Reforming the Stethoscope Industry, Sales to Reach US$ 431 Million by 2022
    The stethoscope market analysis offered by Fact.MR scrutinizes key growth factors that are impacting sales in the market.
  • NEW YORK, Sept. 14, 2022 /PRNewswire/ --The global stethoscopes market is likely to grow from US$ 431 million in 2022 to US$ 504 million by 2026, with sales accelerating at a CAGR of 4% between 2022 and 2026.
  • Similarly, innovation in stethoscope technology and growing popularity of electronic stethoscope will further propel sales in the market during the next 5 years.
  • In 2021, Eko, a leading stethoscope manufacturer, launched a modern stethoscope with built-in AI features.

AIpidata Launches Its Pi-Health App to Bridge the Gaps of Non-Verbal Patients

Retrieved on: 
Wednesday, September 7, 2022
Conditional sentence, CEO, Caregiver, Artificial intelligence, Disability, Stethoscope, Parent, App, Alzheimer's disease, Stardust, Communication, Telemetry, Automation, Health, Headache, AI, Patient, Medical device

Manchester, United Kingdom--(Newsfile Corp. - September 7, 2022) - AIpidata rolls out its Pi-Health App for bridging the communication gaps of non-verbal patients.

Key Points: 
  • Manchester, United Kingdom--(Newsfile Corp. - September 7, 2022) - AIpidata rolls out its Pi-Health App for bridging the communication gaps of non-verbal patients.
  • The App monitors their symptoms with the use of wearable technology and its digital platform.
  • It detects the patient's health condition using a smart pouch worn by them and automatically relays the information to the digital App in real-time.
  • Aipidata aims to achieve a broader reach of this impactful health app.

Caregility and Eko Partner to Bring Smart Stethoscope Technology to Award-Winning Enterprise Telehealth Platform

Retrieved on: 
Thursday, August 18, 2022
Cloud, FDA, SVP, Stethoscope, Eko, Hospital, Business, ECG, Highland Capital Partners, PCG, Telenursing, DUO, Patient, Mark (given name), Twitter, Sutter Health, Partnership, Workflow, Lung, APS, Software, Mayo Clinic, Heart, LinkedIn, Auscultation, API, Medical device

EATONTOWN, N.J. and OAKLAND, Calif., Aug. 18, 2022 /PRNewswire/ -- Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. Caregility's cloud platform now seamlessly integrates with Eko's smart stethoscopes and software, enabling users of Caregility's iConsult application to perform high-quality auscultation (heart, lung, and other body sounds) on patients during a virtual physical exam.

Key Points: 
  • EATONTOWN, N.J. and OAKLAND, Calif., Aug. 18, 2022 /PRNewswire/ -- Caregility, an enterprise telehealth platform company, and Eko , the market leader in stethoscopes for telehealth, today announced an integration partnership.
  • The integration is compatible with Eko's complete line of smart stethoscopes , including the CORE Digital Stethoscope Attachment, 3M Littmann CORE Digital Stethoscope, and DUO ECG + Digital Stethoscope.
  • Users wirelessly connect an Eko stethoscope directly with a Caregility APS telehealth device or tablet with just one touch.
  • Caregility customers and healthcare institutions interested in integrating Eko into the Caregility telehealth platform can attend an educational webinar on August 25.

FDA Clears Eko's Heart Disease Detection AI for Adults and Pediatrics

Retrieved on: 
Tuesday, July 12, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Method, Valvular heart disease, Cardiovascular disease, Character, Phonocardiogram, GP, Health, Practitioner, Highland Capital Partners, Stethoscope, Centers for Disease Control and Prevention, European Heart Journal, ECG, Patient, CEO, EMAS, Adult, Center, Heart, Food, Algorithm, Database, Degenerative disease, Heart sounds, Northwestern Medicine, Diagnosis, FDA, Heart murmur, Sutter Health, Software, Medicine, Mayo Clinic, Medical imaging, Medical device, Pharmaceutical industry, S1

OAKLAND, Calif., July 12, 2022 /PRNewswire/ -- Eko, a digital health company advancing heart and lung disease detection, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Eko Murmur Analysis Software (EMAS) for detecting and characterizing murmurs found in adults and pediatric patients. The next generation of Eko's murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and differentiate, between innocent and structural, heart murmurs indicative of valvular heart disease.

Key Points: 
  • The next generation of Eko's murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and differentiate, between innocent and structural, heart murmurs indicative of valvular heart disease.
  • Valvular heart disease is a life-threatening condition diagnosed in more than 8 million Americans1and is often first identified with a stethoscope.
  • "By making heart disease screening algorithms and digital stethoscopes accessible in exam rooms around the country, we are moving towards a future in which more objective and consistent valvular heart disease screening can become the standard of care."
  • Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients, Heart 2018;104:18321835. doi:10.1136/heartjnl-2018-313082

Global Hospital-Acquired Infection Diagnostics Market Size is Expected to Reach $5.6 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Infectious Diseases, Hospitals, Health, Efficiency, Patient, Conditional sentence, Percussion section, COVID-19, Application, Blood, Subclinical infection, Pasteurization, Obesity, Prevalence, Risk, Endoscopy, CAGR, Stethoscope, SSIS, Incidence, Disinfectant, Spinal cord injury, Safety, Sterilization, Eyeish, Global, Medical device, Dentistry

The Global Hospital-Acquired Infection Diagnostics Market size is expected to reach $5.6 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period.

Key Points: 
  • The Global Hospital-Acquired Infection Diagnostics Market size is expected to reach $5.6 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period.
  • As the need for surgical instruments grows along with the number of surgical procedures performed, the risk of healthcare-associated infections is expected to rise.
  • A growing understanding of the value of sterilized and disinfected medical tools and devices is expected to help drive demand for nosocomial infection control equipment.
  • Other factors driving sales of hospital obtained infection control systems include the increased frequency of chronic diseases and advances in surgical equipment.

Eko Recognized with Second Consecutive MedTech Breakthrough Award for AI Innovation in Healthcare

Retrieved on: 
Thursday, May 5, 2022
Patient engagement in Canada, Atrial fibrillation, Ventricular fibrillation, Journal of the American Heart Association, Global health, Fitness, GLOBE, Â, Algorithm, Neck, Degenerative disease, Heart failure, Highland Capital Partners, Cardiovascular disease, Mayo Clinic, Heart, Patient, Exercise, Heart sounds, Valvular heart disease, Program, FDA, Diagnosis, Incidence, Hospital, Sutter Health, Journal, Artificial intelligence, Workflow, Leadership, MHealth, Health, Medtech, Stethoscope, ECG, American Heart Association, CEO, Technology, Genomic and Medical Data, Intelligence, Pharmaceutical industry, Medical device, Health care

MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.

Key Points: 
  • MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
  • This technology provides frontline healthcare professionals with a reliable, affordable, and scalable solution to screen for cardiovascular disease.
  • The result is improved diagnosis and this technology from Eko is a true breakthrough in every sense of the word.
  • The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.